Management_of_chiasmal_and_hypothalamic_gliomas_of_infancy_and_childhood_with_chemotherapy._Between_March,_1983,_and_February,_1989,_19_infants_or_children_with_chiasmal/hypothalamic_gliomas_were_treated_with_chemotherapy_after_either_surgical_or_radiological_diagnosis._The_patients_ranged_in_age_from_15_weeks_to_15.6_years_(median_3.2_years)_at_the_start_of_therapy._Twelve_patients_were_treated_immediately_after_diagnosis_because_of_progressive_symptoms,_and_seven_received_chemotherapy_after_either_radiographic_progression_or_clinical_deterioration,_including_progressive_visual_loss_or_intracranial_hypertension._Based_on_biopsy_results,_seven_of_these_tumors_were_classified_as_juvenile_pilocytic_astrocytomas,_two_as_astrocytomas,_two_as_highly_anaplastic_astrocytomas,_and_one_as_a_subependymal_giant-cell_astrocytoma._There_was_associated_neurofibromatosis_in_four_patients._The_two_initial_patients_were_treated_with_either_actinomycin_D_and_vincristine_or_5-fluorouracil,_hydroxyurea,_and_6-thioguanine._The_remaining_patients_received_nitrosourea-based_therapy;_15_evaluable_patients_were_treated_with_a_five-drug_regimen_that_included_6-thioguanine,_procarbazine,_dibromodulcitol,_1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea_(CCNU),_and_vincristine_and_one_received_1,3-bis(2-chloroethyl)-1-nitrosourea_(BCNU)_and_5-fluorouracil._Fifteen_of_the_18_evaluable_patients_initially_managed_with_chemotherapy_either_responded_to_therapy_or_their_condition_stabilized._Median_time_to_tumor_progression_has_not_been_reached_at_a_median_follow-up_period_of_79_weeks_(range_6.6_to_303_weeks),_and_no_tumor-related_death_has_occurred_with_a_median_follow-up_period_of_79_weeks_(range_18_to_322_weeks)_from_the_initiation_of_therapy._The_four_patients_who_failed_therapy_or_whose_disease_progressed_after_chemotherapy_were_treated_satisfactorily_with_radiation_therapy._Initial_improvement_or_stabilization_of_visual_function_was_obtained_in_16_patients._Endocrine_function_remained_stable_in_all_patients_during_treatment,_although_three_patients_required_pharmacological_treatment_for_endocrinopathy_that_was_present_at_diagnosis._These_preliminary_results_suggest_that_nitrosourea-based_cytotoxic_regimens_are_useful_for_the_initial_treatment_of_children_with_chiasmal/hypothalamic_gliomas,_and_allow_potentially_harmful_radiation_therapy_to_be_deferred_until_progression_of_disease.